Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer Board Authorizes Broad Evaluation of Strategic Alternatives to Maximize Stockholder Value; Board Recommends Cypress Stockholders NOT Tender Shares Into Ramius Offer
Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer Board Authorizes Broad Evaluation of Strategic Alternatives to Maximize Stockholder Value; Board Recommends Cypress Stockholders NOT Tender Shares Into Ramius Offer
Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer Board Authorizes Broad Evaluation of Strategic Alternatives to Maximize Stockholder Value; Board Recommends Cypress Stockholders NOT Tender Shares Into Ramius Offer
Submitted by
moderatora
on September 28, 2010 - 10:50am
Source:
Marketwatch
News Tags:
Cypress Bioscience
Ramius
Headline:
Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer Board Authorizes Broad Evaluation of Strategic Alternatives to Maximize Stockholder Value; Board Recommends Cypress Stockholders NOT Tender Shares Into Ramius Offer
Do Not Allow Advertisers to Use My Personal information
